- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 20:54 | Jefferies cuts Precision BioSciences stock price target on valuation | ||
| 20:54 | Mizuho reiterates Relmada stock rating on positive cancer trial data | ||
| 20:42 | Village Super Market declares $0.25 dividend per Class A share | ||
| 20:42 | PHX Energy declares $0.20 quarterly dividend, payable April 15 | ||
| 19:42 | TotalEnergies shuts down 15% of production amid Middle East conflict | ||
| 19:42 | Runway Growth Finance stock holds at Hold on dividend coverage concerns | ||
| 19:18 | MSC Income Fund closes $150 million private notes offering | ||
| 19:18 | Energisa Q4 2025 slides: net income surges 150%, leverage rises | ||
| 19:18 | Guggenheim reiterates Liberty Formula One stock Buy on race cancellations | ||
| 19:18 | Evercore sees polyethylene prices up 6-7 cents embedded in Dow, LyondellBasell stock | ||
| 19:18 | Stifel reiterates Colliers stock Buy rating after Savills deal | ||
| 19:18 | William Blair reiterates PAR Technology stock rating after convertible debt offering | ||
| 19:18 | Truist reiterates Charles Schwab stock rating on record trading | ||
| 19:18 | Morgan Stanley reiterates Sana Biotechnology stock rating on diabetes data | ||
| 18:54 | Howden Joinery executives purchase shares through incentive plan | ||
| 18:54 | Wheaton Precious Metals Q4 2025 slides: record results, $4.3B deal | ||
| 18:54 | Angel Studios Q4 2025 slides: 254% revenue surge amid profitability concerns | ||
| 18:54 | Bank of America recommends selling oil above $100 on policy risk | ||
| 18:54 | Lucid Capital cuts Runway Growth Finance stock price target on valuation | ||
| 18:30 | Jefferies cuts Mineralys Therapeutics price target on drug concerns | ||
| 18:30 | Oppenheimer raises Nektar Therapeutics price target to $140 | ||
| 18:30 | BMO cuts UiPath stock price target on AI monetization concerns | ||
| 18:06 | Kainos CFO transfers 1.5M shares to spouse in divorce settlement | ||
| 18:06 | Interactive Strength confirms Ergatta deal, raises 2026 revenue target | ||
| 18:06 | J&J reports 89% response rate for bladder cancer treatment |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.